Cryofocus Medtech (Shanghai) Co (HKSE:06922) Accounts Receivable : HK$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Cryofocus Medtech (Shanghai) Co's accounts receivables for the quarter that ended in Dec. 2024 was HK$0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Cryofocus Medtech (Shanghai) Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 0.00.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Cryofocus Medtech (Shanghai) Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was HK$-0.07.

Cryofocus Medtech (Shanghai) Co Accounts Receivable Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Accounts Receivable Chart

Cryofocus Medtech (Shanghai) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Receivable

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Receivable	Get a 7-Day Free Trial			-	0.02	-	-	-

Cryofocus Medtech (Shanghai) Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Cryofocus Medtech (Shanghai) Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Cryofocus Medtech (Shanghai) Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	36.361	*	91
=	0.00

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Cryofocus Medtech (Shanghai) Co's accounts receivable are only considered to be worth 75% of book value:

Cryofocus Medtech (Shanghai) Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(48.534	+	0.75 * 0	+	0.5 * 31.893	-	75.074
-	0	-	5.427)	/	239.110
=	-0.07

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Cryofocus Medtech (Shanghai) Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 3399, Kangxin Road, Building 15, Pudong New Area, Shanghai, CHN, 200120

Website

https://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products. The products offered by the company include; Bladder Cryoablation System, Pulmonary Nodule Localization Needle, and Endoscopic Clip for Anastomosis among others. Geographically, the company's revenue is generated from the sale of medical consumables and devices in the Chinese Mainland.

Executives

Zhuhai Junheng Investment L.p. (limited Partnership)	2101 Beneficial owner
Shang Hai Shi Di Sheng Wu Ke Ji You Xian Gong Si
Lv Shiwen	2103 Interests held jointly with another person
Shenzhen Gao Ling Tiancheng Iii Investment Co., Ltd.	2201 Interest of corporation controlled by you
Ning Bo Lin Feng Sheng Wu Ke Ji You Xian Gong Si
Wu Jianhui	2101 Beneficial owner
Li Hui	2202 Interest of your spouse
Shang Hai Shi Di Shi Ye Fa Zhan You Xian Gong Si
Sun Xiaolu	2201 Interest of corporation controlled by you
Fu Guo Ji Jin Guan Li You Xian Gong Si	2102 Investment manager
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi He Huo Qi Ye You Xian He Huo
Shang Hai Bi Lin Xing Zi Chan Guan Li You Xian Gong Si
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Sheng Shan Zi Chan Guan Li Shang Hai You Xian Gong Si
Gan Shi Xiong

Cryofocus Medtech (Shanghai) Co Headlines

No Headlines